URGCP Antikörper (AA 501-600) (HRP)
Kurzübersicht für URGCP Antikörper (AA 501-600) (HRP) (ABIN678302)
Target
Alle URGCP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 501-600
-
Homologie
- Human,Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human URG4
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- URGCP (Upregulator of Cell Proliferation (URGCP))
-
Andere Bezeichnung
- URG4
-
Hintergrund
-
Synonyms: FLJ20654, HBV X protein up-regulated gene 4 protein, HBV X protein upregulated gene 4 protein, HBxAg up-regulated gene 4 protein, HBxAg upregulated gene 4 protein, KIAA1507, Up-regulator of cell proliferation, Upregulated gene 4, Upregulator of cell proliferation, URGCP, URGCP_HUMAN.
Background: URG4 may be involved in cell cycle progression through the regulation of cyclin D1 expression. It may participate in the development of hepatocellular carcinoma (HCC) by promoting hepatocellular growth and survival. URG4 may play an important role in development of gastric cancer.
Target
-